RhythmAnalytics vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Powerful Medical

AI Verdict

Both RhythmAnalytics and PMcardio are AI-powered platforms designed for ECG interpretation and clinical decision support in cardiology. RhythmAnalytics focuses on automated interpretation of cardiac arrhythmias from single-lead ECG data, while PMcardio offers a broader assessment of over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, with additional features like visual AI explainability and 3D heart visualization. The choice between them would depend on the specific scope of ECG analysis required and the desired level of diagnostic breadth.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, continuous monitoring and interpretation of cardiac arrhythmias from single-lead ECG data, especially when integrating with existing FDA-cleared ECG devices like Holter monitors or wearable sensors. It's ideal for healthcare solution integrators and organizations focused on comprehensive arrhythmia detection and management in adult patients.

View RhythmAnalytics →

Choose PMcardio if…

Choose PMcardio if you require rapid, expert-level interpretation of 12-lead ECGs for a broad spectrum of over 50 cardiac conditions, including critical acute events like STEMI/OMI and reduced LVEF, at the point of care. It is particularly well-suited for emergency physicians, GPs, nurses, paramedics, and cardiologists who need instant AI-powered insights, visual AI explainability, and compatibility with various ECG formats, including smartphone photos of paper printouts.

View PMcardio →

When choosing between RhythmAnalytics and PMcardio, physicians should consider their primary use case and desired integration. RhythmAnalytics excels in automated, continuous monitoring and interpretation of cardiac arrhythmias from single-lead ECG data. Its cloud-based API deployment makes it ideal for integration into existing systems that handle data from various FDA-cleared ECG devices, such as Holter monitors, event recorders, and wearable sensors. This tool is best suited for practices or institutions focused on long-term rhythm analysis and requiring robust, automated clinical decision support for arrhythmia detection across a broad range of cardiac events.

In contrast, PMcardio is designed for rapid, point-of-care ECG interpretation, assessing over 50 cardiac conditions, including critical findings like STEMI/OMI and reduced LVEF. Its mobile app and web platform, along with enterprise integrations, offer flexibility for clinicians needing immediate insights. The key practical difference lies in their deployment and focus: RhythmAnalytics is a backend solution for automated arrhythmia interpretation from diverse ECG sources, while PMcardio provides a front-end, interactive platform for comprehensive, on-demand ECG analysis. Physicians prioritizing quick, expert-level interpretations at the point of care, with features like visual AI explainability and a freemium model for individual use, would find PMcardio more suitable. Those requiring seamless, automated arrhythmia detection from continuous or intermittent ECG data streams across a larger patient population would lean towards RhythmAnalytics.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics PMcardio
Pricing Contact vendor Freemium
Deployment Cloud-based API Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, allowing for instant AI-powered ECG interpretations directly at the point of care. RhythmAnalytics, while cloud-based, is primarily an API for integration, suggesting a less direct and immediate user experience for individual clinicians. PMcardio's ability to digitize and improve the quality of various 12-lead ECGs, even from suboptimal images, further enhances its usability in diverse clinical settings.

Clinical Value

PMcardio

PMcardio detects over 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF, and provides visual AI explainability with heatmaps. RhythmAnalytics detects over 15 types of cardiac arrhythmias. PMcardio also offers patient management recommendations based on ESC guidelines, enhancing its clinical utility beyond just diagnosis.

Pricing & Value

PMcardio

PMcardio offers a freemium model with a free plan for 5 ECG analyses per month, and transparent pricing for individual, team, and organizational plans. RhythmAnalytics' pricing is listed as 'contact vendor,' which offers less transparency and flexibility for potential users.

Enterprise Readiness

PMcardio

PMcardio is designed for enterprise integration with EHR/CVIS and EMS systems, offers regional data residency, role-based access control, SSO, and full audit trails. It is also SOC 2 Type II and ISO 27001 compliant, in addition to HIPAA and GDPR. RhythmAnalytics is a cloud-based API compatible with FDA-cleared ECG devices, but its enterprise features are less explicitly detailed.

Innovation

PMcardio

PMcardio demonstrates greater innovation with features like Queen of Heartsu2122 for STEMI and OMI detection, LVsenseu2122 for reduced LVEF detection, and ECGxplainu2122 for visual AI explainability. It also offers patient management recommendations based on clinical guidelines. RhythmAnalytics focuses on automated interpretation of cardiac arrhythmias from single-lead ECG data.

Support & Docs

PMcardio

PMcardio provides a Help Center with user-friendly tutorials and manuals, an FAQ section, and a dedicated research page with publications and clinical research information. RhythmAnalytics' documentation and support resources are not explicitly detailed in the provided information, making it difficult to assess their comprehensiveness.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics PMcardio
Name RhythmAnalytics PMcardio
Company Biofourmis Singapore Pte. Powerful Medical
Tagline AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support. AI that reads ECGs in seconds
Key Features (Arrhythmia Detection) Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies)

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics is a cloud-based API, suggesting it's designed for integration into existing systems. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and can export detailed PDF reports that can be integrated into patient electronic health records.
RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib and ventricular arrhythmias. PMcardio is clinically validated in over 25 studies and detects more than 50 ECG findings, including STEMI/OMI, reduced LVEF, and conduction disorders. PMcardio has demonstrated high accuracy for AF detection (sensitivity and specificity of 1.00 in one study) and improved sensitivity for STEMI detection compared to traditional criteria.
RhythmAnalytics is designed for Cardiology, Emergency Medicine, and Internal Medicine, focusing on automated interpretation of cardiac arrhythmias. PMcardio is utilized by emergency physicians, GPs, nurses, paramedics, and cardiologists, addressing acute emergency detection (STEMI/OMI), echo screening (reduced LVEF, aortic stenosis), remote monitoring, and even consumer wearables.
PMcardio emphasizes speed and simplicity, with a mobile app and web platform designed for ease of use. While RhythmAnalytics is an API, implying a backend integration, the user-facing interface would depend on the integrating system. PMcardio's ability to digitize and improve the quality of old or damaged ECG strips may also simplify usage in varied clinical settings.
PMcardio offers in-app customer support via Zendesk and provides user-friendly tutorials and manuals through its Help Center. RhythmAnalytics' support structure is not explicitly detailed, but as an API-based solution, it would likely involve developer support for integration and maintenance.
PMcardio generates professional PDF diagnostic reports that include digitized ECGs, patient and ECG-related information, and a transcript of the full chat history linked to the ECG report, which can be exported and integrated into EHRs. This provides a clear audit trail of the AI's interpretation and any associated clinical context.
PMcardio is built for system-wide rollout with enterprise deployment patterns, connecting to existing ECG systems, EHR/CVIS, and EMS systems, and scaling across campuses and care settings without custom builds. It also applies relevant AI models automatically for each clinical context, such as STEMI/OMI detection on acute ECGs or LVEF estimation on routine ECGs.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.